SOCS3 and primary cutaneous T-cell non-Hodgkin lymphoma: Indeed, constitutive SOCS-3 expression has been reported for cutaneous T-cell lymphoma lines, and reversal of this expression was associated with increased sensitivity to interferon γ inhibition of proliferation (Brender et al, 2001).